404 results on '"Vescovo, Giorgio"'
Search Results
2. Effects of concomitant administration of anticancer agents and apixaban or dalteparin on recurrence and bleeding in patients with cancer-associated venous thromboembolism
3. Early Time Courses of Recurrent Venous Thromboembolism and Bleeding during Apixaban or Dalteparin Therapy for Patients with Cancer
4. Stem cells transplantation positively modulates the heart-kidney cross talk in cardiorenal syndrome type II
5. Lipopolysaccharide in systemic circulation induces activation of inflammatory response and oxidative stress in cardiorenal syndrome type 1
6. Early Time Courses of Recurrent Thromboembolism and Bleeding during Apixaban or Dalteparin Therapy for Patients with Cancer
7. The contribution of stem cell therapy to skeletal muscle remodeling in heart failure
8. Current presentation and management of 7148 patients with atrial fibrillation in cardiology and internal medicine hospital centers: The ATA AF study
9. Decision making for oral anticoagulants in atrial fibrillation: The ATA-AF study
10. Real-world economic burden of venous thromboembolism and antithrombotic prophylaxis in medical inpatients
11. The mechanisms of muscle wasting in COPD and heart failure
12. Long QT, alteration of calcium-phosphate product, prevalence of ventricular arrhythmias and sudden death in peritoneal dialysis patients: a Holter study
13. Hemodynamic Progression and Outcome of Asymptomatic Aortic Stenosis in Primary Care
14. Stem-cell therapy in an experimental model of pulmonary hypertension and right heart failure: Role of paracrine and neurohormonal milieu in the remodeling process
15. Anti-hypertensive treatment in pheochromocytoma and paraganglioma: current management and therapeutic features
16. Skeletal muscle proteins oxidation in chronic right heart failure in rats: Can different beta-blockers prevent it to the same degree?
17. The Role of Congestion in Cardiorenal Syndrome Type 2: New Pathophysiological Insights into an Experimental Model of Heart Failure
18. Neuromuscular junction fragmentation and muscle wasting in heart failure: a sharp cut from a Sica† sword?
19. Cardiorenal Syndrome Type 1: Activation of Dual Apoptotic Pathways
20. Cardiorenal Syndrome Type 1: A Defective Regulation of Monocyte Apoptosis Induced by Proinflammatory and Proapoptotic Factors
21. Skeletal muscle wastage in Crohn's disease: A pathway shared with heart failure?
22. The Hemodynamic and Nonhemodynamic Crosstalk in Cardiorenal Syndrome Type 1
23. Unexpectedly High Recanalization Rate in Patients with Pulmonary Embolism Treated with Anticoagulants Alone
24. Pain assessment in non-communicative patients: the Italian version of the Non-Communicative Patient’s Pain Assessment Instrument (NOPPAIN)
25. Skeletal muscle myofibrillar protein oxidation and exercise capacity in heart failure
26. Skeletal muscle abnormalities in rats with experimentally induced heart hypertrophy and failure
27. Beneficial effects of GH/IGF-1 on skeletal muscle atrophy and function in experimental heart failure
28. Effects of iloprost on pain-free walking distance and clinical outcome in patients with severe stage IIb peripheral arterial disease: the FADOI 2bPILOT Study
29. Cardiorenal Syndromes: An Executive Summary from the Consensus Conference of the Acute Dialysis Quality Initiative (ADQI)
30. L-carnitine: a potential treatment for blocking apoptosis and preventing skeletal muscle myopathy in heart failure
31. Cardiorenal Syndrome Type 1 May Be Immunologically Mediated: A Pilot Evaluation of Monocyte Apoptosis
32. The Role of Cell-Free Plasma DNA in Patients with Cardiorenal Syndrome Type 1
33. Biomarkers in kidney and heart disease
34. Evolving concepts in disseminating medical science and the challenge of COVID-19
35. Apixaban for the Treatment of Venous Thromboembolism Associated with Cancer
36. Prevention of cardio-renal syndromes: workgroup statements from the 7th ADQI Consensus Conference
37. Epidemiology of cardio-renal syndromes: workgroup statements from the 7th ADQI Consensus Conference
38. Definition and classification of Cardio-Renal Syndromes: workgroup statements from the 7th ADQI Consensus Conference
39. Cardio-renal syndromes: report from the consensus conference of the Acute Dialysis Quality Initiative
40. Skeletal muscle fibres synthesis in heart failure: Role of PGC-1α, calcineurin and GH
41. Skeletal muscle myosin heavy chains in heart failure: correlation between magnitude of the isozyme shift, exercise capacity, and gas exchange measurements
42. Heart–kidney crosstalk and role of humoral signaling in critical illness
43. Angiotensin II and contraction of isolated myocytes from human, guinea pig, and infarcted rat hearts
44. Time trends in three triennial surveys of cardiovascular risk factors and their treatment among patients discharged from divisions of internal medicine: The FAPOI-1, FADOI-2, and FADOI-3 studies
45. Editorial
46. Apoptosis in the Skeletal Muscle of Rats with Heart Failure is Associated with Increased Serum Levels of TNF-α and Sphingosine
47. Rationale and study design of intravenous loop diuretic administration in acute heart failure: DIUR-AHF
48. Plasma Lipopolysaccharide Concentrations in Cardiorenal Syndrome Type 1
49. Data on the stem cells paracrine effects on apoptosis and cytokine milieu in an experimental model of cardiorenal syndrome type II
50. Editorial
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.